NLRP3: More than an Inflammasome?

被引：1
作者：
Pennings, Gabrielle J. [1 ]
机构：
[1] Univ Sydney, ANZAC Res Inst Sydney Local Hlth Dist, Concord, NSW, Australia
来源：
THROMBOSIS AND HAEMOSTASIS | 2024年 / 124卷 / 12期
关键词：
PHARMACOLOGICAL INHIBITION; ACTIVATION;
D O I：
10.1055/a-2413-4672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1114 / 1116
页数：3
相关论文
共 21 条
  • [1] Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis
    Aganna, E
    Martinon, F
    Hawkins, PN
    Ross, JB
    Swan, DC
    Booth, DR
    Lachmann, HJ
    Gaudet, R
    Woo, P
    Feighery, C
    Cotter, FE
    Thome, M
    Hitman, GA
    Tschopp, J
    McDermott, MF
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2445 - 2452
  • [2] Megakaryocyte NLRP3 hyperactivation induces mild anemia and potentiates inflammatory response in mice
    Bourne, Joshua H.
    Campos, Joana
    Hopkin, Sophie J.
    Whitworth, Katharine
    Palis, James
    Senis, Yotis A.
    Rayes, Julie
    Iqbal, Asif J.
    Brill, Alexander
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Inflammasome-Independent Mechanism of NLRP3 Is Critical for Platelet GPIb-IX Function and Thrombosis
    Chen, Xiaoyan
    Li, Jingke
    Liu, Pu
    Zhou, Yangfan
    Zhang, Tongtong
    Li, Li
    Shi, Jingqi
    Deng, Xin
    Sheng, Yilin
    Chen, Wei
    Wang, Di
    Hu, Hu
    [J]. THROMBOSIS AND HAEMOSTASIS, 2024, 124 (12) : 1095 - 1113
  • [4] MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition
    Coll, Rebecca C.
    Hill, James R.
    Day, Christopher J.
    Zamoshnikova, Alina
    Boucher, Dave
    Massey, Nicholas L.
    Chitty, Jessica L.
    Fraser, James A.
    Jennings, Michael P.
    Robertson, Avril A. B.
    Schroder, Kate
    [J]. NATURE CHEMICAL BIOLOGY, 2019, 15 (06) : 556 - +
  • [5] Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950
    Corcoran, Sarah E.
    Halai, Reena
    Cooper, Matthew A.
    [J]. PHARMACOLOGICAL REVIEWS, 2021, 73 (03) : 968 - 1000
  • [6] NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
    Grebe, Alena
    Hoss, Florian
    Latz, Eicke
    [J]. CIRCULATION RESEARCH, 2018, 122 (12) : 1722 - 1740
  • [7] Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis
    Hettwer, Jan
    Hinterdobler, Julia
    Miritsch, Benedikt
    Deutsch, Marcus-Andre
    Li, Xinghai
    Mauersberger, Carina
    Moggio, Aldo
    Braster, Quinte
    Gram, Hermann
    Robertson, Avril A. B.
    Cooper, Matthew A.
    Gross, Olaf
    Krane, Markus
    Weber, Christian
    Koenig, Wolfgang
    Soehnlein, Oliver
    Adamstein, Nicholas H.
    Ridker, Paul
    Schunkert, Heribert
    Libby, Peter
    Kessler, Thorsten
    Sager, Hendrik B.
    [J]. CARDIOVASCULAR RESEARCH, 2022, 118 (13) : 2778 - 2791
  • [8] Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation
    Hottz, Eugenio D.
    Lopes, Juliana F.
    Freitas, Carla
    Valls-de-Souza, Rogerio
    Oliveira, Marcus F.
    Bozza, Marcelo T.
    Da Poian, Andrea T.
    Weyrich, Andrew S.
    Zimmerman, Guy A.
    Bozza, Fernando A.
    Bozza, Patricia T.
    [J]. BLOOD, 2013, 122 (20) : 3405 - 3414
  • [9] The role of NLRP3 inflammasome in aging and age-related diseases
    Liang, Ruikai
    Qi, Xinrui
    Cai, Qi
    Niu, Liyan
    Huang, Xi
    Zhang, Deju
    Ling, Jitao
    Wu, Yuting
    Chen, Yixuan
    Yang, Pingping
    Liu, Jianping
    Zhang, Jing
    Yu, Peng
    [J]. IMMUNITY & AGEING, 2024, 21 (01)
  • [10] Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
    Ma, Qiang
    [J]. PHARMACOLOGICAL REVIEWS, 2023, 75 (03) : 487 - 520
123